First Human Embryos Genetically Modified Using CRISPR-Cas9 DNA-editing Technique

Developmental biologists of the Karolinska Institute in Stockholm, Sweden have joined only a handful of others in a quest to genetically edit human embryos using CRISPR/Cas-9 technology. The controversial endeavor has underlined ethics talks on modification of human embryonic DNA, also known as ‘germline modification’. The Swedish group has pushed the boundaries by using viable [Read More]

Stem Cells to Treat Unborn Babies with Debilitating Genetic Disease

osteogenesis imperfecta (OI) PRP treatment

In a preemptive approach to treat a debilitating genetic disease, scientists in Germany and the United States are planning clinical trials to use stem cell therapy to treat osteogenesis imperfecta (OI) in ailing fetuses. Occurring in about one in 20,000 live births, OI is the result of a gene mutation that leads to a deficiency [Read More]

Get our newsletter for the latest news & updates.

Share the knowledge: